At least twice as many patients on the approved spesolimab dose maintain improvement in skin symptoms and quality of life ...

Some triggers may increase your risk of developing this form of psoriasis. These include: Occasionally, the pustules can cover the entire body, which is known as generalized pustular psoriasis ...

After considering the feedback from consultation, the appraisal committee has prepared final draft guidance (FDG) on spesolimab for treating generalised pustular psoriasis flares and submitted it to ...

Fast Five Quiz: Generalized Pustular Psoriasis How much do you know about generalized pustular psoriasis? Assess your knowledge with this quick quiz. Medscape Reference, May 15, 2025 S3 Episode 4 ...

Spesolimab for preventing generalised pustular psoriasis flares [ID6216] Technology appraisal guidance TBC Spesolimab for preventing generalised pustular psoriasis flares in people 12 years and over ...

German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in ...

BI 655130, a new biological entity, has already shown “remarkable efficacy” in early clinical testing with a single dose in patients affected by generalised pustular psoriasis. Results support ...

The spectrum of suspected cutaneous toxicity includes exacerbation of plaques, photosensitivity, generalised erythroderma, evolution to pustular psoriasis, and the development of an exfoliative ...

LEO Pharma A/S, a global leader in medical dermatology, today announced the initiation of the phase 2a proof-of-concept DELTA NEXT trial. The trial aims to evaluate the efficacy and safety of ...